Secretary Leavitt served as Administrator of the U.S. Environmental Protection Agency and Governor of Utah. While at EPA, Administrator Leavitt signed the Clean Air Diesel Rule, implemented new, more-protective air quality standards for ozone and fine particle pollution and organized a regional collaboration of national significance to clean and protect the Great Lakes. Sec. Leavitt is widely recognized as a health care innovator and welfare reformer, and his record of achievement in Utah bears this out. He was chosen by the nation's governors to represent the states in Congress on welfare reform, Medicaid and children's health insurance. As Secretary of Health and Human Services he is committed to unleashing the power of technology to improve the quality of care, reduce mistakes and manage costs.
Klaus Stöhr, D.V.M.
Dr. Klaus Stöhr is the Project Leader for World Health Organization Global Influenza Programme. Dr. Stohr trained as a veterinarian in East Germany and later became an expert in diseases that are transmitted from animals to people. He joined the WHO in 1992. More recently he played a crucial role in the WHO investigation of SARS and now is leading the WHO’s efforts to prepare for an influenza pandemic.
John Treanor, M.D.
Dr. Treanor received his MD degree from the University of Rochester in Rochester NY and Internal Medicine internship and residency training at the University of Vermont, in Burlington, Vermont. He then did clinical and research training in Infectious Diseases at the University of Rochester and in the Laboratory of Infectious Diseases, NIH, Bethesda MD. Since 1988 Dr. Treanor has been a member of the Infectious Diseases Unit at the University of Rochester, where he directs the Vaccines and Treatments Evaluation Unit (VTEU). Dr. Treanor’s primary research interests include clinical virology and clinical trials, especially related to clinical evaluation of novel vaccines for influenza. Current projects are related to candidate pandemic vaccines, approaches to intranasal vaccination using live or inactivated vaccines, and use of expressed recombinant proteins as vaccines.
Robert Webster, Ph.D., F.R.S.
Dr. Webster is the Rose Marie Thomas Chair of the Virology Division of the Department of Infectious Diseases at St. Jude Children’s Research Hospital in Memphis, Tenn. In addition to his position at St. Jude, he is Director of the U.S. Collaborating Center of the World Health Organization (WHO), dealing with the ecology of animal influenza viruses. The center is the world’s only laboratory designed to study influenza at the animal-human interface. Dr. Webster’s interests include the structure and function of influenza virus proteins and the development of new vaccines and antivirals; the importance of influenza viruses in wild birds as a major reservoir of influenza viruses and their role in the evolution of new pandemic strains for humans and lower animals.